Journal of Biopharmaceutical Statistics

Papers
(The H4-Index of Journal of Biopharmaceutical Statistics is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life14
Implementing the meta-analytic approach for the evaluation of surrogate endpoints in SAS and R: a word of caution13
Comment on ‘statistical consideration and challenges in bridging study of personalized medicine’: a modified variance for sensitivity analysis11
Borrowing historical information to improve phase I clinical trials using meta-analytic-predictive priors10
Heterogeneous logistic regression for estimation of subgroup effects on hypertension10
A Bayesian three-tier quantitative decision-making framework for single arm studies in early phase oncology9
Estimands, Handling of Missing Data and Impact on Assumed Effect Size and Power in Pivotal COVID-19 Treatment Trials9
Multi-stage dose expansion cohort (MSDEC) design with Bayesian stopping rule9
Risk difference, relative risk, and odds ratio for non-inferiority clinical trials with risk rate endpoint9
0.058781147003174